Jefferies Maintains Buy on Insulet

Jefferies is out with its report today on Insulet PODD, maintaining Buy. In a note to clients, Jefferies writes, "As profitability is emerging, EV/Sales is the best valuation method. We use the 5.0x current multiple rolled forward to 2012 EV/Sales to arrive at a $24/share target and we rate PODD Buy." Shares of PODD closed Wednesday at $18.59, up 0.92% from Tuesday's close.